Viewing data from:

GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE

ANDA

GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE | A091071 | ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC

2 strengths0 unique patents0 unique exclusivities

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 2, 2015	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 600MG;60MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: May 27, 2015

No patent or exclusivity listings for this strength.

#002 — 1.2GM;120MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: May 27, 2015